Cargando…

Brain Metastasis in Patients with Small Cell Lung Cancer

PURPOSE: To characterize the risk factors for brain metastasis (BM) at presentation and analyze the prognostic factors for patients with small cell lung cancer (SCLC). PATIENTS AND METHODS: Patients were recruited from the SEER database between 2010 and 2016. They were divided into two groups accord...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Na, Chu, Yuxin, Song, Qibin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710975/
https://www.ncbi.nlm.nih.gov/pubmed/34992434
http://dx.doi.org/10.2147/IJGM.S342009
_version_ 1784623281544888320
author Li, Na
Chu, Yuxin
Song, Qibin
author_facet Li, Na
Chu, Yuxin
Song, Qibin
author_sort Li, Na
collection PubMed
description PURPOSE: To characterize the risk factors for brain metastasis (BM) at presentation and analyze the prognostic factors for patients with small cell lung cancer (SCLC). PATIENTS AND METHODS: Patients were recruited from the SEER database between 2010 and 2016. They were divided into two groups according to BM status. The incidence trends of SCLC and its BM were analyzed by joinpoint software. The risk factors for BM in SCLC were identified by binary logistic regression models. The prognostic factors for SCLC patients with BM were identified by Cox proportional hazard models. RESULTS: The incidence of SCLC and its BM significantly decreased after 2010. Totally 11,093 patients were collected, including 1717 (15.5%) patients with BM and 9376 (84.5%) patients without BM. In multivariate logistic regression analysis, age, male and higher T stage were independent risk factors for BM in SCLC patients at presentation. SCLC patients with BM showed inferior survival to those without BM. In multivariate Cox regression analysis, increasing age, large tumor size, and higher N stage were risk factors for poor prognosis, while other race, surgery, adjuvant radiotherapy, and chemotherapy were protective factors for SCLC patients with BM. A nomogram was developed for prognosis evaluation of such patients. CONCLUSION: Age, male and higher T stage were risk factors for BM in SCLC patients at presentation. Increasing age, large tumor size, and advanced N stage may predict poor survival for SCLC patients with BM. Multidisciplinary therapies may provide clinical benefits. This study will help identify patients with higher BM risk and hopefully improve their clinical outcome.
format Online
Article
Text
id pubmed-8710975
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-87109752022-01-05 Brain Metastasis in Patients with Small Cell Lung Cancer Li, Na Chu, Yuxin Song, Qibin Int J Gen Med Original Research PURPOSE: To characterize the risk factors for brain metastasis (BM) at presentation and analyze the prognostic factors for patients with small cell lung cancer (SCLC). PATIENTS AND METHODS: Patients were recruited from the SEER database between 2010 and 2016. They were divided into two groups according to BM status. The incidence trends of SCLC and its BM were analyzed by joinpoint software. The risk factors for BM in SCLC were identified by binary logistic regression models. The prognostic factors for SCLC patients with BM were identified by Cox proportional hazard models. RESULTS: The incidence of SCLC and its BM significantly decreased after 2010. Totally 11,093 patients were collected, including 1717 (15.5%) patients with BM and 9376 (84.5%) patients without BM. In multivariate logistic regression analysis, age, male and higher T stage were independent risk factors for BM in SCLC patients at presentation. SCLC patients with BM showed inferior survival to those without BM. In multivariate Cox regression analysis, increasing age, large tumor size, and higher N stage were risk factors for poor prognosis, while other race, surgery, adjuvant radiotherapy, and chemotherapy were protective factors for SCLC patients with BM. A nomogram was developed for prognosis evaluation of such patients. CONCLUSION: Age, male and higher T stage were risk factors for BM in SCLC patients at presentation. Increasing age, large tumor size, and advanced N stage may predict poor survival for SCLC patients with BM. Multidisciplinary therapies may provide clinical benefits. This study will help identify patients with higher BM risk and hopefully improve their clinical outcome. Dove 2021-12-21 /pmc/articles/PMC8710975/ /pubmed/34992434 http://dx.doi.org/10.2147/IJGM.S342009 Text en © 2021 Li et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Li, Na
Chu, Yuxin
Song, Qibin
Brain Metastasis in Patients with Small Cell Lung Cancer
title Brain Metastasis in Patients with Small Cell Lung Cancer
title_full Brain Metastasis in Patients with Small Cell Lung Cancer
title_fullStr Brain Metastasis in Patients with Small Cell Lung Cancer
title_full_unstemmed Brain Metastasis in Patients with Small Cell Lung Cancer
title_short Brain Metastasis in Patients with Small Cell Lung Cancer
title_sort brain metastasis in patients with small cell lung cancer
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710975/
https://www.ncbi.nlm.nih.gov/pubmed/34992434
http://dx.doi.org/10.2147/IJGM.S342009
work_keys_str_mv AT lina brainmetastasisinpatientswithsmallcelllungcancer
AT chuyuxin brainmetastasisinpatientswithsmallcelllungcancer
AT songqibin brainmetastasisinpatientswithsmallcelllungcancer